| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $262.1M | — | +9.6% |
| Cost of Revenue | $56.7M | — | +8.0% |
| Gross Profit | $205.4M | — | +10.0% |
| R&D Expense | $55.8M | — | +4.8% |
| SG&A Expense | $31.4M | — | -34.5% |
| Operating Income | $8.8M | — | +149.5% |
| Income Tax | $3.7M | — | +1.6% |
| Net Income | $1.4M | — | +106.2% |
| EPS (Basic) | $0.01 | — | +105.3% |
| EPS (Diluted) | $0.01 | — | +105.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $139.2M | -25.9% | -40.4% |
| Short-term Investments | $221.1M | +3.1% | -2.5% |
| Accounts Receivable | $170.3M | -39.0% | +1.5% |
| Current Assets | $647.2M | -16.3% | -13.3% |
| Total Assets | $1.62B | -7.3% | -4.3% |
| Current Liabilities | $762.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $88.0M | — | +0.6% |
| Capital Expenditures | $2.6M | — | -60.5% |
| Investing Cash Flow | -$12.2M | — | +90.8% |
| Financing Cash Flow | -$123.7M | — | -143.1% |
| Free Cash Flow | $85.4M | — | +5.6% |
| +6.6% |
| Total Liabilities | $1.37B | -3.5% | +4.7% |
| Stockholders' Equity | $248.2M | -23.9% | -35.2% |